Literature DB >> 21929652

Subtypes of irritable bowel syndrome on Rome III criteria: a multicenter study.

Xin Yao1, Yun Sheng Yang, Li Hong Cui, Ka Bing Zhao, Zhen Hua Zhang, Li Hua Peng, Xu Guo, Gang Sun, Jun Shang, Wei Feng Wang, Jia Feng, Qiyang Huang.   

Abstract

BACKGROUND AND AIM: The aim of this study was to explore the distribution and clinical characteristics of four subtypes of irritable bowel syndrome (IBS) based on Rome III criteria in Chinese.
METHODS: A total of 754 consecutive IBS outpatients from three tertiary hospitals in China were included. Diagnostic criteria were based on Rome II or Rome III.
RESULTS: Among 754 outpatients, 510 (67.6%) patients met the Rome II criteria, 735 (97.5%) patients met the Rome III criteria and 492 (65.3%) patients met both sets of criteria. Among 735 patients who met the Rome III criteria, 66.3% had IBS with diarrhea (IBS-D), 14.7% had IBS with constipation (IBS-C), 4.2% had mixed IBS (IBS-M) and 14.8% had unsubtyped IBS (IBS-U). Most of the IBS-D, IBS-C and IBS-M patients based on the Rome III criteria matched the diarrhea-predominant IBS, constipation-predominant IBS and alternating IBS based on the Rome II criteria, respectively. Among IBS-U patients, 57.0%, 33.3% and 9.7% had constipation-predominant IBS, diarrhea-predominant IBS and alternating IBS, respectively. For IBS-M, the frequencies of bowel movements were stable in 48.4% patients and variable in 51.6% patients. Defecation urgency and straining were most frequent in IBS-M and least frequent in IBS-U patients than other subtypes. About 77.2% of IBS-U patients had abnormal stool frequency (< 3 times/week or > 3 times/day).
CONCLUSION: The Rome III criteria are more sensitive and practical in diagnosing IBS. IBS-D is the most frequent subtype, which is followed by IBS-U, IBS-C and IBS-M. IBS-U is a new subtype, which warrants further studies.
© 2011 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 21929652     DOI: 10.1111/j.1440-1746.2011.06930.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  24 in total

1.  Characterization of symptoms in irritable bowel syndrome with mixed bowel habit pattern.

Authors:  A M Su; W Shih; A P Presson; L Chang
Journal:  Neurogastroenterol Motil       Date:  2013-08-29       Impact factor: 3.598

2.  Comparison of Manning, Rome I, II, and III, and Asian diagnostic criteria: report of the Multicentric Indian Irritable Bowel Syndrome (MIIBS) study.

Authors:  Uday C Ghoshal; Philip Abraham; Shobna J Bhatia; Sri Prakash Misra; Gourdas Choudhuri; K D Biswas; Karmabir Chakravartty; Sunil Dadhich; B D Goswami; V Jayanthi; Sunil Kumar; Abraham Koshy; K R Vinay Kumar; Govind Makharia; Sandeep Nijhawan; Nitesh Pratap; Gautam Ray; Sanjeev Sachdeva; Shivaram Prasad Singh; Varghese Thomas; Harsh Udawat
Journal:  Indian J Gastroenterol       Date:  2013-09-03

3.  High-sensitive C-Reactive Protein as a Marker for Inflammation in Irritable Bowel Syndrome.

Authors:  Keren Hod; Tamar Ringel-Kulka; Christopher F Martin; Nitsan Maharshak; Yehuda Ringel
Journal:  J Clin Gastroenterol       Date:  2016-03       Impact factor: 3.062

Review 4.  Fecal microbiota transplantation: in perspective.

Authors:  Shaan Gupta; Emma Allen-Vercoe; Elaine O Petrof
Journal:  Therap Adv Gastroenterol       Date:  2016-03       Impact factor: 4.409

5.  Effect of Lactobacillus gasseri BNR17 on irritable bowel syndrome: a randomized, double-blind, placebo-controlled, dose-finding trial.

Authors:  Ji Yeon Kim; Yeo Jin Park; Hyo Jin Lee; Min Young Park; Oran Kwon
Journal:  Food Sci Biotechnol       Date:  2017-12-12       Impact factor: 2.391

6.  Efficacy of tandospirone in patients with irritable bowel syndrome-diarrhea and anxiety.

Authors:  Ling Lan; Yu-Long Chen; Hao Zhang; Bai-Ling Jia; Yan-Jun Chu; Jin Wang; Shi-Xiao Tang; Guo-Dong Xia
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

7.  JCM-16021, a Chinese Herbal Formula, Attenuated Visceral Hyperalgesia in TNBS-Induced Postinflammatory Irritable Bowel Syndrome through Reducing Colonic EC Cell Hyperplasia and Serotonin Availability in Rats.

Authors:  Hong-Yan Qin; Hai-Tao Xiao; Fung-Ping Leung; Zhi-Jun Yang; Justin C Y Wu; Joseph J Y Sung; Hong-Xi Xu; Xu-Dong Tong; Zhao-Xiang Bian
Journal:  Evid Based Complement Alternat Med       Date:  2012-06-10       Impact factor: 2.629

8.  Effect of TongXie-YaoFang on Cl(-) and HCO3 (-) Transport in Diarrhea-Predominant Irritable Bowel Syndrome Rats.

Authors:  Xiaofang Lu; Shengsheng Zhang; Cheng Yang; Zhengfang Wang; Luqing Zhao; Zhenyu Wu; Jing Xie
Journal:  Evid Based Complement Alternat Med       Date:  2016-06-14       Impact factor: 2.629

9.  A school-based study with Rome III criteria on the prevalence of functional gastrointestinal disorders in Chinese college and university students.

Authors:  Yan-Yan Dong; Fei-Xue Chen; Yan-Bo Yu; Chao Du; Qing-Qing Qi; Han Liu; Yan-Qing Li
Journal:  PLoS One       Date:  2013-01-18       Impact factor: 3.240

Review 10.  Fecal biomarkers of intestinal health and disease in children.

Authors:  Tamara Pang; Steven T Leach; Tamarah Katz; Andrew S Day; Chee Y Ooi
Journal:  Front Pediatr       Date:  2014-01-28       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.